Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Myositis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07331272
What this trial is testing

LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathies(IIM)
Nanjing Legend Biotech Co. 38
Not applicableUnknownNCT06379646
What this trial is testing

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 6
Very early researchWithdrawnNCT07410377
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory Myopathy
The Affiliated Hospital of Xuzhou Medical University
Testing effectiveness (Phase 2)Study completedNCT02043548
What this trial is testing

Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis

Who this might be right for
DermatomyositisPolymyositis
Chester Oddis 36
Early research (Phase 1)Active Not RecruitingNCT05869955
What this trial is testing

CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathySystemic Sclerosis+1 more
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 270
Not applicableUnknownNCT06373081
What this trial is testing

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
Shanghai Changzheng Hospital 6
Testing effectiveness (Phase 2)WithdrawnNCT07012057
What this trial is testing

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

Who this might be right for
MyositisDermatomyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not applicableLooking for participantsNCT07403188
What this trial is testing

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

Who this might be right for
Refractory Lupus NephritisMyasthaenia GravisStiff Person Syndrome+4 more
Kyverna Therapeutics 70
Early research (Phase 1)Looking for participantsNCT07184450
What this trial is testing

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

Who this might be right for
Juvenile Dermatomyositis (JDM)Polyarticular Juvenile Idiopathic ArthritisSystemic Sclerosis (SSc)+1 more
Chongqing Precision Biotech Co., Ltd 11
Very early researchLooking for participantsNCT07301164
What this trial is testing

Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases

Who this might be right for
System Lupus ErythematosusSystemic Sclerosis (SSc)Inflammatory Myositis+3 more
Peking University Third Hospital 10
Early research (Phase 1)Looking for participantsNCT07236801
What this trial is testing

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic SclerosisSjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Early research (Phase 1)Not Yet RecruitingNCT06978738
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusAutoimmune Hemolytic AnemiaMyasthenia Gravis+4 more
Changzhou No.2 People's Hospital 18
Very early researchNot Yet RecruitingNCT06986018
What this trial is testing

Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV

Who this might be right for
Idiopathic Inflammatory MyopathiesANCA-Associated Vasculitis
Peking University People's Hospital 12
Early research (Phase 1)Active Not RecruitingNCT06255028
What this trial is testing

CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more
Century Therapeutics, Inc. 6
Early research (Phase 1)UnknownNCT06056921
What this trial is testing

Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Sjogren's SyndromeSystemic Scleroderma+2 more
Chongqing Precision Biotech Co., Ltd 24
Early research (Phase 1)Looking for participantsNCT06941129
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis (SSc)Inflammatory Myopathy+3 more
Institute of Hematology & Blood Diseases Hospital, China 12
Not applicableLooking for participantsNCT06614270
What this trial is testing

Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)ANCA Associated Vasculitis (AAV)Idiopathic Inflammatory Myopathy (IIM)+3 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 15
Testing effectiveness (Phase 2)Looking for participantsNCT06350110
What this trial is testing

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisAutoimmune Diseases+6 more
Essen Biotech 75
Post-approval studies (Phase 4)Study completedNCT02245841
What this trial is testing

Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis

Who this might be right for
DermatomyositisJuvenile Dermatomyositis
The Cleveland Clinic 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT06665256
What this trial is testing

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

Who this might be right for
Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals 21
Next Page